Click here to read an updated version of this article.
The company reported a rise in second-quarter revenues to $6.2 million, versus $6 million in the year-ago quarter, an increase the company attributed to both the addition of new customers and the upgrading of the firm's analysis systems by existing customers.
Sequenom's research and development spending dropped to about $3 million in the quarter from $5.7 million a year earlier.
The company posted a net loss of $6 million, or $.15 per share, versus a year-ago loss of $9.8 million, or $.25 per share.
As of June 30, Sequenom had cash, cash equivalents, short-term investments, and restricted cash totaling $25.4 million.